featured
Real-World Use of Control-IQ Technology Is Associated With Lower Rates of Severe Hypoglycemia and Diabetic Ketoacidosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study
Diabetes Technol. Ther. 2024 Jan 01;26(1)24-32, R Graham, L Mueller, M Manning, S Habif, LH Messer, JE Pinsker, E Aronoff-SpencerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.